Is this looking better now? Thanks GutOnc, visari, ETA, MikeScott, CD19/20, Pertuzumab and others who have been really helpful.
Emory
RPCI
Utah
MCW
Karmanos
Florida
Kentucky
Cincinnati
Stony Brook
Utah and RPCI are still equally desirable and I'm not sure which one to rank 2. The reason I'm leaning towards RPCI is that the center is more comprehensive (no major weak areas) and has more research opportunities than Utah. But then, Utah has a better fellowship program structure, has a non-malignant atmosphere and is very strong in malignant heme and GU (my current interests).
MCW is a great program - good vibe, great hospital, decent staff, blood research institute and substantially better NCI+NHLBI funding than Karmanos.
For the last 4, I'm not sure where Kentucky and Florida fit.